"The
Report Mesenchymal Stem Cells - Advances & Applications 2013
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Understand and profit from the
mesenchymal stem cell (MSC) product market – the fastest growing
area of stem cell research.
Mesenchymal stem cells (MSCs)
are multipotent stem cells that can differentiate into a variety of
cell types, including osteoblasts, chondrocytes, myocytes,
adipocytes, beta-pancreatic islets cells, and potentially, neuronal
cells. MSCs are of intense therapeutic interest because they
represent a population of cells with the potential to treat a wide
range of acute and degenerative diseases.
MSCs are advantageous over
other stem cells types for a variety of reasons: they avoid the
ethical issues that surround embryonic stem cell research, and
repeated studies have found MSCs to be immuno-privileged, which make
them an advantageous cell type for allogenic transplantation. MSCs
reduce both the risks of rejection and complications of
transplantation. Recently, there have been advances in the use of
autologous mesenchymal stem cells to regenerate human tissues,
including cartilage, meniscus, tendons, bone fractures, and more.
View Report At
:http://www.marketresearchreports.biz/analysis/174818
Trend analysis of grant
activity, scientific publication rates, and patent applications
trends reveal that global research activity involving mesenchymal
stem cells (MSCs) increased 112% from 2009 to 2010, and 116% from
2010 to 2011. Of most interest is that this rate of growth
accelerated throughout 2011, making mesenchymal stem cells the
fastest growing area of stem cell research.
Because mesenchymal stem cell
researchers represent a rapidly growing, well-funded research
community, this report presents strategies for research supply
companies to use to develop high-demand products for this community.
A key element of this report is a survey of mesenchymal stem cell
(MSC) researchers. This survey reveals critical findings that
include:
- Preferred Tissue Source for MSCs
- Preferred Species Source for MSCs
- MSC Product Preferences
- Most Commonly Utilized MSC Antibodies
- Terms Used in Online Search (for targeting your ads with precision)
It is also important for
bio-pharmaceutical and pharma companies interested in mesenchymal
stem cell therapy applications to understand underlying market
forces, and in particular, to consider progressive areas of MSC
research as opportunistic areas for drug and therapy development.
This report presents a range of topics of interest to these companies
as well, including how advances in MSC research can reveal potential
new drug targets, improve methods of drug delivery, and provide
personalized treatment strategies.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/174818
Highlights of this report
include:
- Charts, Timelines, Metrics and Financials
- Rates of MSC Grants, Publications, and Patents
- Market Characterization and 5-Year Projections
- Breakdown of MSC Research Activity by Application, Species, Tissue Source
- Geographical Assessment of Market Demand
- Competitive Environment Analysis, by MSC Product Supplier
- Recent Product Evolution and Unmet Market Needs
- Online Advertising Assessment and Opportunities for Targeted Traffic
- Revealing Survey of Your Prospective Clients MSC Scientists
- End-User Wants, Technical Preferences, Factors Influencing Buying Decisions
And Much More...
The market intelligence
contained in this report was compiled using a broad range of sources,
including:
- MSC grant funding (NIH database, DoD database)
- MSC patents (USPTO)
- MSC publications (PubMed, Highwire Press)
- MSC product launch announcements (Google News, Trade Journals)
- International surveys (electronically distributed end-user surveys)
And more
These sources were used to
identify recent advances in MSC research applications, explore
research priorities by market segment, highlight individual labs and
end-users of MSC research products, explore the competitive
environment for MSC research products, and provide 5-year growth and
trend analysis. As such, this market intelligence report will
advantageously position your company to offer competitive MSC
products to this rapidly growing, well-funded research community.
You'll also access
information on:
- Recent Product Evolution
- Projected Directions for Development
- Overview of Therapeutic Progress and Insight into Future Applications
- Detailed Evaluation of Profit Opportunities for Research Product Suppliers
In summary, literature and data
concerning the biology and differentiation potential of mesenchymal
stem cells (MSCs) has become huge in less than 10 years, now totaling
nearly 13,000 publications, although some data does present as
contradictory, suggesting a heterogenic nature for MSC populations
depending on source tissue, species, and donor characteristics. MSCs
appear to be an exceptionally promising tool for cell therapy because
of their unusual characteristics, which partially mimic those of
embryonic stem cells, but have advantages in terms of availability,
expandability, transplantability, and ethical implications.
Interest in therapeutic
applications of human MSCs arises from their diverse ability to
differentiate into a range of cell types, as well as from their
ability to migrate to sites of tissue injury/inflammation or tumor
growth. These localization properties present a promising strategy
for targeted introduction of therapeutic agents through MSC gene
therapy. In addition, MSCs possess strong immunosuppressive
properties that medical researchers are exploiting for both
autologous as well as heterologous therapies.
Characterized by these
properties, it not surprising that trend analysis reveals rapid
increases in research activity involving mesenchymal stem cells. With
scientific publication rate increases of 112% year-over-year from
2009 to 2010, and 116% from 2010 to 2011, this report will help you
understand and profit from the mesenchymal stem cell (MSC) product
market – the fastest growing area of stem cell research.
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
Of Content
I. Abstract
II. Overview
A. Definition
B. Alternative Nomenclature
C. Identification
1. Characteristics
2. Functional Attributes
D. Benefits Relative to Other
Stem Cell Types
III. Sources
A. Fetal
B. Adult
IV. Cell Types Derived from
MSCs
V. Applications
A. Basic Research Applications
1. Directed Differentiation of
Autologous MSCs to Intra-Mesenchymal Lineages
2. Directed Differentiation of
Autologous MSCs to Extra-Mesenchymal Lineages
B. Supporting Hematopoietic
Cells
C. Gene Transfer Applications
D. Cell Transplantation for
Site-Specific Repair
1. Overview
2. Major Applications
a. Osteogenic-Focused Research
Labs
b. Myogenic and Myocardial
Repair
c. Neural Repair
c. Pancreatic Repair
E. Topical Therapy and Use of
MSCs in Wound Healing
F. Use of MSC in 3-D Scaffolds
for Tissue Engineering Applications
G. Drug Delivery Applications:
Engineered MSCs as Carriers of Anti-Cancer Drugs
H. Drug Screening
I. MSC-mediated Inhibition of
Immune Effector Cells
VI. Application Priorities
A. Overall
B. By Segment
1. Academic
2. Biotechnology
3. Pharmaceutical
VII. Companies Offering Human
MSC Research Products
A. Abcam
B. BD Biosciences
C. Celprogen
D. Cyagen Biosciences (China
only)
E. Invitrogen
F. LGC Standards/ATCC
G. Lonza
H. Millipore
I. Miltenyi Biotec
J. PAA - The Cell Culture
Company
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment